Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Evaluation of Seravue Device Sensitivity and Specificity for Surveillance and Diagnosis of Patients at Risk for Hepatocellular Carinoma (HCC)

NCT06994130 is registered in ClinicalTrials.gov with ImCare Biotech as lead sponsor.

NCT NCT06994130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06994130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Evaluation of Seravue Device Sensitivity and Specificity for Surveillance and Diagnosis of Patients at Risk for Hepatocellular Carinoma (HCC)
Lead sponsor
ImCare Biotech
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2025
Completion date
August 31, 2029
Enrollment
1,392 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic cancer